These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5620799)

  • 21. Pituitary gland ablation by 90yttrium implantation for advancing diabetic retinopathy. A further report.
    Cullen JF; Gibson PF; Maccuish AC; Harris P; Donaldson AA; Munro JF; Duncan LJ
    Br J Ophthalmol; 1971 Apr; 55(4):217-24. PubMed ID: 5572265
    [No Abstract]   [Full Text] [Related]  

  • 22. Pituitary ablation by means of intrasellar implantation of 90 Y in the treatment of diabetic retinopathy.
    Dogliotti GC; Molinatti GM; Camanni F; Losana O; Massara F
    Panminerva Med; 1968 Jun; 10(6):229-35. PubMed ID: 5668749
    [No Abstract]   [Full Text] [Related]  

  • 23. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):823-33. PubMed ID: 2062515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired prepapillary vascular veils].
    Bonnet M; Bonamour G
    Arch Ophtalmol Rev Gen Ophtalmol; 1968 Mar; 28(2):123-48. PubMed ID: 4231432
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic changes following irradiation of the pituitary gland with yttrium isotopes for diabetic retinopathy].
    Dub O; Pátek F
    Vnitr Lek; 1969 Nov; 15(11):1082-8. PubMed ID: 5364828
    [No Abstract]   [Full Text] [Related]  

  • 26. [Destruction of the pituitary gland by intrasellar implantation of radioactive yttrium in the treatment of diabetic retinopathy].
    Dogliotti GC; Molinatti GM; Camanni F; Losana O; Massara F
    Minerva Med; 1968 May; 59(43):2505-12. PubMed ID: 5664429
    [No Abstract]   [Full Text] [Related]  

  • 27. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.
    Ophthalmology; 1978 Jan; 85(1):82-106. PubMed ID: 345173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [[Stereo GIHF-indications in failure of treatment of proliferative diabetic retinopathy by pan retinal photocoagulation].
    Constantinides G; Van-Hullebusch A; Lenski C; Schaub C
    Bull Soc Ophtalmol Fr; 1982 Apr; 82(4):603-4. PubMed ID: 6179648
    [No Abstract]   [Full Text] [Related]  

  • 29. Pituitary ablation in the treatment of diabetic retinopathy. (A randomized trial).
    Kohner EM; Joplin GF; Blach RK; Cheng H; Fraser TR
    Trans Ophthalmol Soc U K (1962); 1972; 92():79-90. PubMed ID: 4577661
    [No Abstract]   [Full Text] [Related]  

  • 30. Penetration of retinal and vitreous opacities in diabetic retinopathy. Use of infrared fundus photography.
    Dallow RL; McMeel JW
    Arch Ophthalmol; 1974 Dec; 92(6):531-4. PubMed ID: 4433275
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pituitary ablation on diabetic retinopathy studied by fluorescence angiography.
    Kohner EM; Dollery CT; Fraser TR; Bulpitt CJ
    Diabetes; 1970 Oct; 19(10):703-14. PubMed ID: 5474207
    [No Abstract]   [Full Text] [Related]  

  • 32. [1967 review of studies of the retina--with emphasis on retinal vascular diseases].
    Matsui M
    Ganka; 1968 Oct; 10(10):681-95. PubMed ID: 4885729
    [No Abstract]   [Full Text] [Related]  

  • 33. [Indication for photocoagulation in diabetic retinopathy].
    Leuenberger A
    Klin Monbl Augenheilkd; 1972 Mar; 160(3):269-73. PubMed ID: 5025498
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy.
    Kohner EM; Henkind P
    Am J Ophthalmol; 1970 Mar; 69(3):403-14. PubMed ID: 4907465
    [No Abstract]   [Full Text] [Related]  

  • 35. Pituitary ablation in diabetics with severe retinopathy.
    Madsen PH
    Acta Med Scand; 1970 Nov; 188(5):345-50. PubMed ID: 5490561
    [No Abstract]   [Full Text] [Related]  

  • 36. [Documenting the outcome of photocoagulation for diabetic retinopathy].
    Borgmann H
    Mod Probl Ophthalmol; 1972; 10():652-8. PubMed ID: 5056376
    [No Abstract]   [Full Text] [Related]  

  • 37. Further observations on argon laser photocoagulation of diabetic retinopathy.
    Zweng HC; Little HL; Peabody RR
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(4):990-1004. PubMed ID: 4677399
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of a digital retinal imaging system and seven-field stereo color fundus photography to detect diabetic retinopathy in the primary care environment.
    Schiffman RM; Jacobsen G; Nussbaum JJ; Desai UR; Carey JD; Glasser D; Zimmer-Galler IE; Zeimer R; Goldberg MF
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):46-56. PubMed ID: 15688971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On a case of diabetic retinopathy treated by intrahypophyseal implantation (development during 7 years)].
    Ceruti F; Poujol J; Guyard M
    Bull Soc Ophtalmol Fr; 1967 Jan; 67(1):218-21. PubMed ID: 5611489
    [No Abstract]   [Full Text] [Related]  

  • 40. Pituitary ablation by yttrium-90 implants for diabetic retinopathy.
    FRASER R; JOPLIN GF; STEINER RE
    Diabetes; 1962; 11():482-3. PubMed ID: 13959343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.